stockrow
Saturday 7 November 2026
Export DBVT’s income statement to Excel — free account
DBV Technologies S.A.
DBVT Healthcare Biotechnology
DBV Technologies S.A.’s revenue for fiscal 2025 (year ended December 2025) was $5.6 million, up 35.8% from fiscal 2024.
- Revenue
- −42.9%
- EPS
- +40.4%
- Free cash flow
- −64.9%
Quarter to September 2026, against a year earlier
10.57
0.77
+7.86%
Follow DBVT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 5 | 3 | 2 |
| (149.73%) | (158.81%) | (142.63%) | (205.75%) | ||
| (98.17%) | (105.66%) | (95.98%) | (127.19%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(88.90%) | (81.76%) | (111.85%) | (145.33%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(4.36) | (1.77) | (1.97) | (2.13) | |
Free Cash Flow |
(121.74) | (151.51) | (170.57) | (191.71) | |
Capital Expenditures |
(0.56) | (0.93) | (1.29) | (3.33) | |
| Other line items | |||||
Cash ROIC |
(33.54%) | (34.66%) | (50.87%) | (60.96%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
2,070.30% | 2,241.67% | 2,554.34% | 3,867.29% | |
Selling, General and Administrative Expense of Revenue |
638.93% | 791.67% | 1,146.88% | 1,804.34% | |
Share Based Compensation of Revenue |
95.58% | 104.38% | 171.94% | 342.26% | |
Interest Coverage |
— | 361.84 | — | — | |
Operating CF/Net income |
0.82 | 0.90 | 0.96 | 0.91 | |
Depreciation/Fixed assets |
0.31 | 0.31 | 0.31 | 0.24 | |
Capex/Depreciation |
(0.18) | (0.30) | (0.43) | (1.19) | |
Revenue per Share |
0.20 | 0.07 | 0.06 | 0.04 | |
Operating CF per Share |
(4.34) | (1.76) | (1.95) | (2.09) | |
Capex per Share |
(0.02) | (0.01) | (0.01) | (0.04) | |
Capex to Sales |
0.10 | 0.16 | 0.26 | 0.89 |
Columns are period end dates · fundamentals updated 2 Nov 2026